Topic
Surgical Oncology
39 Podcasts • 12 Cases • 6 Courses on BackTable
Hear how experienced clinicians in Surgical Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 323 • 11 Aug 2026
Managing Intermediate-Risk Bladder Cancer
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common, progression is uncommon, and the burden of repeated procedures can add up quickly. On this episode of the BackTable Urology Podcast, Dr. Ruchika Talwar interviews Dr. Charles "Chas" Peyton about how to manage intermediate-risk bladder cancer patients while balancing disease control and quality of life. They discuss the cumulative impact of repeated TURBTs and explore the evolving role of office-based treatments and chemoablative therapies as alternatives to the traditional treatment cycle.
More on Surgical Oncology
Loading recent podcasts…
Urology # 323
Aug 10, 2026
with Dr. Charles Peyton, Dr. Ruchika Talwar
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common,...
690+ listens
Urology # 320
Jul 30, 2026
with Dr. Sarah Psutka, Dr. Ruchika Talwar
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...
960+ listens
Tumor Board # 72
Jul 13, 2026
with Dr. Chih-Yi Liao, Dr. Abdul Khan, Dr. Lingling Du
What factors come into play when deciding whether to use liver-directed therapy or systemic therapies for...
180+ listens
Urology # 313
Jun 29, 2026
with Dr. Kirsten Greene, Dr. Ruchika Talwar
Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...
1,300+ listens
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
280+ listens
Urology # 317
Jul 16, 2026
with Dr. George R. Schade, Dr. Tiwa Akinsola
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this...
1,300+ listens
Vascular & IR # 660
Jul 2, 2026
with Dr. David Madoff, Dr. Michael Barraza
How is portal vein embolization (PVE) pushing the boundaries of liver tumor resectability, and what does it take to...
1,600+ listens
Tumor Board # 67
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
40+ listens
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Oct 27, 2025
with Dr. Dylan Roden, Dr. Ravindra Uppaluri and Dr. Adam Luginbuhl
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.